Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Poseida Therapeutics, Inc.

Get SEC filing alerts via email and in your feed for Poseida Therapeutics, Inc.

PSTX

Poseida Therapeutics, Inc.

About Poseida Therapeutics, Inc.

Poseida Therapeutics is a clinical-stage biopharmaceutical company specializing in cell and gene therapies for cancer and rare diseases. Its proprietary platforms enable the development of off-the-shelf CAR-T and gene therapy products with enhanced safety, durability, and manufacturing efficiency. Focused on solid tumors and hematological malignancies, the company leverages advanced gene editing, gene insertion, and delivery technologies to create innovative, scalable treatments aimed at improving efficacy and accessibility.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Poseida Therapeutics, Inc.

1
1
Poseida Therapeutics, Inc. Poseida Therapeutics Reports Significant Revenue Growth, Improved Operational Efficiency in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments